In this webinar, Dr. Sanjaya Gupta, MD, FACC, FHRS shares insight on why choosing to prescribe MCOT® and ePatch™ allows him to better monitor, treat and care for his patients.

In this webinar, Ryan Augenstein and the BioTel Heart EMR team discuss how their successful EMR integration at Parkview Health helped improve the workflow, efficiency, and overall patient care.

Join Philips BioTel Heart for a virtual round table discussion of the past, present and future challenges and solutions providers encounter in the remote management of cardiac patients.

This webinar is co-sponsored by the Cardiac Safety Research Consortium, and will be moderated by Jonathan Seltzer, MD, FACC – CSRC Executive Director.

Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple steatosis and nonalcoholic steatohepatitis (NASH). Patients with non-alcoholic fatty liver disease (NAFLD) are at risk of steatohepatitis and progressive liver fibrosis culminating in cirrhosis, typically over a period of decades. Early diagnosis and risk stratification are essential for effective management. Although liver biopsy is currently the gold standard for diagnosing progressive NASH, it has many drawbacks, such as sampling error, cost and risk of complications. Furthermore, it is not realistic to perform liver biopsies on all NAFLD patients. The limitations of liver biopsy have driven a search for non-invasive NAFLD screening and risk stratification methods. Since advanced fibrosis has been proven to be

Learn from industry expert, Dr. Tim Callahan at this free webinar on the development of clinical trials using targeted agents has been stimulated by the identification of pathways involved in carcinogenesis, metastasis and drug resistance and by the emergence of molecular analysis of tumors.

Please join us for this free webinar on trends in event and continuous ECG monitoring, and implications for clinical trials of both medical devices and drug therapies. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research. Download Full Slide Presentation 

In this free webinar learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.

In this free webinar, industry experts Sandra Chica, MD and Polina Voloshko, MD aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway.